Seres Therapeutics
(NASDAQ) MCRB
Seres Therapeutics Financials at a Glance
Market Cap
$74.95M
Revenue (TTM)
$1.15M
Net Income (TTM)
-$46.90M
EPS (TTM)
-$5.02
P/E Ratio
-1.54
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Price
$7.73
Volume
130,834
Open
$7.95
Price
$7.73
Volume
130,834
Open
$7.95
Previous Close
$7.74
Daily Range
$7.48 - $8.06
52-Week Range
$5.31 - $29.98
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Price
$7.73
Volume
130,834
Open
$7.95
Previous Close
$7.74
Daily Range
$7.48 - $8.06
52-Week Range
$5.31 - $29.98
Estimated Earnings Date
Aug 5, 2026
MCRB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Seres Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
66
CEO
Richard N. Kender, MBA
Website
www.serestherapeutics.comHeadquarters
Cambridge, MA 02139, US
MCRB Financials
Key Financial Metrics (TTM)
Gross Margin
-20.92%
Operating Margin
-7640.98%
Net Income Margin
-4088.84%
Return on Equity
-127.30%
Return on Capital
-73.89%
Return on Assets
-39.87%
Earnings Yield
-64.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$74.95M
Shares Outstanding
9.68M
Volume
130.83K
Avg. Volume
70.76K
Financials (TTM)
Gross Profit
-$240.00K
Operating Income
-$87.64M
EBITDA
-$41.87M
Operating Cash Flow
-$42.15M
Capital Expenditure
-$218.00K
Free Cash Flow
-$42.37M
Cash & ST Invst.
$29.83M
Total Debt
$80.50M
Seres Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$358.00K
N/A
Gross Profit
-$423.00K
+88.0%
Gross Margin
-1.18%
N/A
Market Cap
$74.95M
N/A
Market Cap/Employee
$727.70K
N/A
Employees
103
N/A
Net Income
-$19.91M
-160.9%
EBITDA
-$19.13M
-156.7%
Quarterly Fundamentals
Total Cash
$29.83M
-49.3%
Total Debt
$80.50M
-10.1%
Accounts Receivable
$233.00K
-94.7%
Inventory
$0.00
N/A
Long Term Debt
$69.63M
-13.5%
Short Term Debt
$10.87M
+20.1%
Return on Assets
-39.87%
N/A
Return on Invested Capital
-89.18%
N/A
Free Cash Flow
-$16.36M
-160.9%
Operating Cash Flow
-$16.36M
-160.8%